IME Stock Overview
Offers cloud-based medical imaging solutions in Australia and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ImExHS Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.41 |
| 52 Week High | AU$0.70 |
| 52 Week Low | AU$0.40 |
| Beta | 1.22 |
| 11 Month Change | -10.00% |
| 3 Month Change | -15.63% |
| 1 Year Change | -42.14% |
| 33 Year Change | n/a |
| 5 Year Change | -79.23% |
| Change since IPO | -72.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| IME | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -10.0% | 2.7% | -0.07% |
| 1Y | -42.1% | 121.0% | 16.9% |
Return vs Industry: IME underperformed the Australian Healthcare Services industry which returned 121% over the past year.
Return vs Market: IME underperformed the Australian Market which returned 16.9% over the past year.
Price Volatility
| IME volatility | |
|---|---|
| IME Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 8.2% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.0% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: IME's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine IME's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 400 | German Arango | www.imexhs.com |
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company’s solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis.
ImExHS Limited Fundamentals Summary
| IME fundamental statistics | |
|---|---|
| Market cap | AU$18.48m |
| Earnings (TTM) | -AU$3.42m |
| Revenue (TTM) | AU$24.90m |
0.7x
P/S Ratio-5.4x
P/E RatioIs IME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IME income statement (TTM) | |
|---|---|
| Revenue | AU$24.90m |
| Cost of Revenue | AU$14.92m |
| Gross Profit | AU$9.99m |
| Other Expenses | AU$13.41m |
| Earnings | -AU$3.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.075 |
| Gross Margin | 40.10% |
| Net Profit Margin | -13.73% |
| Debt/Equity Ratio | 5.8% |
How did IME perform over the long term?
See historical performance and comparison